[1] WILCKEN DE,WILCKEN B.The pathogenesis of coronary artery disease.A possible role for methionine metabolism[J].Clin Invest,1976,57(4):1079.
[2] 杨朝美,李逊,马珍,等.血清BNP、hs-CRP、IMA 与冠状动脉粥样硬化性心脏病病人的相关性研究[J].中国实验诊断学,2015,19(7):37.
[3] 欧红萍,李彬,周凤勤,等.颈动脉超声检查联合血清超敏C反应蛋白水平检测在冠状动脉粥样硬化性心脏病诊断中的应用[J].新乡医学院学报,2014,31(10):59.
[4] VEERANNA V,ZALAWADIYA SK,NIRAJ A,et al.Homocysteine and reclassication of cardiovascular disease risk[J].J Am Coll Cardiol,2011,58(10):1025.
[5] 白艳艳,冯六六,黄红漫,等.同型半胱氨酸水平和超敏C 反应蛋白与冠心病的相关性研究[J].中西医结合心脑血管病杂志,2015,13(3):346.
[6] FENG L,XU W,ZHANG X,et al.The associations between serum biomarkers and stenosis of thecoronaryarteries [J].Oncotarget,2016,7(26):39231.
[7] ZHAO LP,YOU T,CHEN JC,et al. Adropin is associated with hyperhomocysteine and coronary atherosclerosis[J].Exp Ther Med,2016,11(3):1065.
[8] PENG HY,MAN CF,XU J,et al. Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies [J].Zhejiang Univ Sci B,2015,16(1):78.
[9] WASKIEWICZ A,SYGNOWSKA E,BRODA G,et al. Homocysteine concentration and the risk of death in the adult polish population[J].Kardiol Pol,2012,70(9):897.
[10] NAESS H,NYLAND H,IDICULA T,et al. C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients[J].Stroke Cerebrovasc Dis,2013,22(8):e435.
[11] SWART KM,VAN SCHOOR NM,BLOM,HJ,et al.Homocysteine and the risk of nursing home admission and mortality in older persons[J].Eur J Clin Nutr,2012,66(2):188.
[12] CASTEJON R,JIMENEZ-ORTIZ C,VALERO-GONZALEZ S,et al.Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus[J].Rheumatology,2014,53(4):631.
[13] SUKMAWATI D,TANAKA R.Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine[J].Am J Transl Res,2015,7(3):411.
[14] ALEXANDRU N,ANDREI E,DRAGAN E,et al.Interaction of platelets with endothelial progenitor cells in the experimental atherosclerosis:role of transplanted endothelial progenitor cells and platelet microparticles[J].Biol Cell,2015,107(6):189.
[15] LAMBERTSEN KL,BIBER K,FINSEN B.Inflammatory cytokines in experimental and human stroke[J].J Cereb Blood Flow Metab,2012,32(9):1677.
[16] CUI G,WANG H,LI R,et al.Polymorphism of tumor necrosis factor α(TNF-α) gene promoter,circulating TNF-α level,and cardiovascular risk facter for ischemic stroke[J].J Neuroinflammation,2012,10(9):235.
[17] 张茵,宋雷,高展,等.血浆C反应蛋白水平与冠心病患者冠状动脉造影结果严重程度相关[J].中国分子心脏病学杂志,2015,2(9):1273.
[18] 孙京花,李健,王成彬,等.红细胞体积分布宽度和超敏C反应蛋白与冠心病的相关性研究[J].检验医学与临床,2015,12(20):3019.
[19] 高阅春,李全,何继强,等.超敏C反应蛋白水平与冠心病严重程度及预后的相关性研究[J].中国全科医学,2012,15 (5):840.
[20] 吕良芬. hs-CRP与动脉粥样硬化相关性分析[J].中西医结合心血管病杂志,2015,3(25):122.
[21] 李凤,朱余友,杨孙凤,等.血清五聚素3、超敏C 反应蛋白、脂蛋白相关磷脂酶A2水平以及微栓子信号与大动脉粥样硬化型急性脑梗死病人颈动脉粥样硬化斑块稳定性的相关研究[J].临床神经病学杂志,2016,29(2):95.
[22]
[23] 陈飞,张贵.同型半胱氨酸与高敏C-反应蛋白在冠心病病人中的临床意义[J].中国实验诊断学,2014,18(4):653.
[24] 王晓洪.同型半胱氨酸与C-反应蛋白水平检测在冠心病诊断中的应用价值[J].中国现代药物应用,2015,9(5):18.
[25] 朱洁莹,李琴,韩丽英,等.同型半胱氨酸联合超敏反应蛋白检测诊断冠状动脉粥样硬化的临床意义[J].心脑血管病防治,2015,15(3):188.